Effects ofMECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype-Reference-Cited by-同舟云学术

Effects ofMECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype

Published:2003-03-19 Issue:2 Volume:118A Page:103-114
ISSN:0148-7299
Container-title:American Journal of Medical Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Weaving Linda S.,Williamson Sarah L.,Bennetts Bruce,Davis Mark,Ellaway Carolyn J.,Leonard Helen,Thong Meow-Keong,Delatycki Martin,Thompson Elizabeth M.,Laing Nigel,Christodoulou John

Publisher

Wiley

Subject

Genetics(clinical)

Reference61 articles.

1. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome

2. Rett syndrome: Methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations

3. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

4. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes

5. 2000. Statistics for social and health research with a guide to SPSS. London: SAGE Publications Ltd.; 538 p.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Clinical Utility of Targeted MECP2 Testing in Real-World Practice;Pediatric Neurology;2024-12

2. The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)—Implications for Parkinson’s Disease and Rett Syndrome;Molecular Neurobiology;2024-03-02

3. MECP2-related disorders while gene-based therapies are on the horizon;Frontiers in Genetics;2024-02-12

4. A Review on Rett Syndrome: A Debilitating Neurodevelopmental Disorder;Research Journal of Pharmacology and Pharmacodynamics;2023-11-09

5. MECP2 Mutations in the Rett Syndrome Patients from South India;Neurology India;2022-01